Common Chinese materia medica . Volume 2 / / edited by Huagu Ye [and three others] |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (588 pages) |
Disciplina | 615.1 |
Soggetto topico |
Pharmacy
Medicina xinesa Medicina tradicional |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-2066-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910492150003321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Common Chinese materia medica . Volume 1 / / Huagu Ye [and three others], editors |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (205 pages) |
Disciplina | 615.1 |
Soggetto topico |
Pharmacy
Medicina xinesa Medicina tradicional |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-2062-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910492140503321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Common Chinese materia medica . Volume 5 / / Huagu Ye [and three others], editors |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (637 pages) |
Disciplina | 615.321 |
Soggetto topico |
Materia medica, Vegetable - China
Materia medica, Vegetable - China - Analysis Fitoteràpia Medicina xinesa |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-5888-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910520060303321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Common Chinese Materia Medica . Volume 3 / / Huagu Ye [and three others], editors |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (579 pages) |
Disciplina | 616 |
Soggetto topico |
Clinical medicine
Fitoteràpia Medicina xinesa |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-5880-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Participating Units -- Preface -- Abstract -- Contents -- Chapter 1: Medicinal Angiosperms of Onagraceae, Trapaceae, Haloragidaceae, Thymelaeaceae, Nyctaginaceae, Proteaceae, Dilleniaceae, and Pittosporaceae -- 1.1 Family: Onagraceae -- 1.1.1 Epilobium hirsutum -- 1.2 Family: Onagraceae -- 1.2.1 Epilobium pyrricholophum -- 1.3 Family: Onagraceae -- 1.3.1 Ludwigia adscendens -- 1.4 Family: Onagraceae -- 1.4.1 Ludwigia hyssopifolia -- 1.5 Family: Onagraceae -- 1.5.1 Ludwigia octovalvis -- 1.6 Family: Onagraceae -- 1.6.1 Ludwigia prostrata -- 1.7 Family: Trapaceae -- 1.7.1 Trapa bispinosa -- 1.8 Family: Haloragidaceae -- 1.8.1 Haloragis chinensis -- 1.9 Family: Haloragidaceae -- 1.9.1 Haloragis micrantha -- 1.10 Family: Thymelaeaceae -- 1.10.1 Aquilaria sinensis [1] -- 1.11 Family: Thymelaeaceae -- 1.11.1 Daphne genkwa -- 1.12 Family: Thymelaeaceae -- 1.12.1 Daphne papyracea -- 1.13 Family: Thymelaeaceae -- 1.13.1 Edgeworthia chrysantha -- 1.14 Family: Thymelaeaceae -- 1.14.1 Wikstroemia indica [2] -- 1.15 Family: Nyctaginaceae -- 1.15.1 Boerhavia diffusa -- 1.16 Family: Proteaceae -- 1.16.1 Helicia cochinchinensis [3] -- 1.17 Family: Proteaceae -- 1.17.1 Helicia reticulata -- 1.18 Family: Dilleniaceae -- 1.18.1 Tetracera asiatica -- 1.19 Family: Pittosporaceae -- 1.19.1 Pittosporum brevicalyx -- 1.20 Family: Pittosporaceae -- 1.20.1 Pittosporum glabratum -- 1.21 Family: Pittosporaceae -- 1.21.1 Pittosporum pauciflorum -- 1.22 Family: Pittosporaceae -- 1.22.1 Pittosporum tobira -- References -- Chapter 2: Medicinal Angiosperms of Flacourtiaceae, Tamaricaceae, Passifloraceae, and Cucurbitaceae -- 2.1 Family: Flacourtiaceae -- 2.1.1 Flacourtia rukam -- 2.2 Family: Flacourtiaceae -- 2.2.1 Hydnocarpus hainanensis -- 2.3 Family: Flacourtiaceae -- 2.3.1 Idesia polycarpa -- 2.4 Family: Flacourtiaceae -- 2.4.1 Xylosma controversa.
2.5 Family: Flacourtiaceae -- 2.5.1 Xylosma longifolia -- 2.6 Family: Flacourtiaceae -- 2.6.1 Xylosma racemosum -- 2.7 Family: Tamaricaceae -- 2.7.1 Tamarix chinensis -- 2.8 Family: Passifloraceae -- 2.8.1 Adenia chevalieri -- 2.9 Family: Passifloraceae -- 2.9.1 Passiflora caerulea -- 2.10 Family: Passifloraceae -- 2.10.1 Passiflora cupiformis -- 2.11 Family: Passifloraceae -- 2.11.1 Passiflora foetida -- 2.12 Family: Passifloraceae -- 2.12.1 Passiflora kwangtungensis -- 2.13 Family: Passifloraceae -- 2.13.1 Passiflora moluccana var. teysmanniana -- 2.14 Family: Cucurbitaceae -- 2.14.1 Actinostemma tenerum -- 2.15 Family: Cucurbitaceae -- 2.15.1 Benincasa hispida [1] -- 2.16 Family: Cucurbitaceae -- 2.16.1 Gynostemma pentaphyllum -- 2.17 Family: Cucurbitaceae -- 2.17.1 Lagenaria siceraria -- 2.18 Family: Cucurbitaceae -- 2.18.1 Luffa acutangula [2] -- 2.19 Family: Cucurbitaceae -- 2.19.1 Luffa aegyptiaca [3] -- 2.20 Family: Cucurbitaceae -- 2.20.1 Momordica charantia -- 2.21 Family: Cucurbitaceae -- 2.21.1 Momordica cochinchinensis -- 2.22 Family: Cucurbitaceae -- 2.22.1 Neoalsomitra integrifoliola -- 2.23 Family: Cucurbitaceae -- 2.23.1 Siraitia grosvenorii -- 2.24 Family: Cucurbitaceae -- 2.24.1 Solena amplexicaulis -- 2.25 Family: Cucurbitaceae -- 2.25.1 Thladiantha longifolia -- 2.26 Family: Cucurbitaceae -- 2.26.1 Thladiantha nudiflora -- 2.27 Family: Cucurbitaceae -- 2.27.1 Trichosanthes kirilowii, Trichosanthes rosthornii -- 2.28 Family: Cucurbitaceae -- 2.28.1 Trichosanthes laceribractea -- 2.29 Family: Cucurbitaceae -- 2.29.1 Zehneria indica -- 2.30 Family: Cucurbitaceae -- 2.30.1 Zehneria maysorensis -- References -- Chapter 3: Medicinal Angiosperms of Begoniaceae, Cactaceae, and Theaceae -- 3.1 Family: Begoniaceae -- 3.1.1 Begonia cavaleriei -- 3.2 Family: Begoniaceae -- 3.2.1 Begonia crassirostris -- 3.3 Family: Begoniaceae. 3.3.1 Begonia evansiana -- 3.4 Family: Begoniaceae -- 3.4.1 Begonia fimbristipula -- 3.5 Family: Begoniaceae -- 3.5.1 Begonia palmata -- 3.6 Family: Begoniaceae -- 3.6.1 Begonia pedatifida [1] -- 3.7 Family: Cactaceae -- 3.7.1 Opuntia stricta var. dillenii [2] -- 3.8 Family: Theaceae -- 3.8.1 Adinandra millettii -- 3.9 Family: Theaceae -- 3.9.1 Anneslea fragrans -- 3.10 Family: Theaceae -- 3.10.1 Camellia japonica -- 3.11 Family: Theaceae -- 3.11.1 Camellia oleifera [3] -- 3.12 Family: Theaceae -- 3.12.1 Camellia sinensis -- 3.13 Family: Theaceae -- 3.13.1 Eurya chinensis -- 3.14 Family: Theaceae -- 3.14.1 Eurya distichophylla -- 3.15 Family: Theaceae -- 3.15.1 Eurya impressinervis -- 3.16 Family: Theaceae -- 3.16.1 Eurya nitida -- 3.17 Family: Theaceae -- 3.17.1 Schima argentea -- 3.18 Family: Theaceae -- 3.18.1 Schima superba -- 3.19 Family: Theaceae -- 3.19.1 Ternstroemia gymnanthera -- 3.20 Family: Theaceae -- 3.20.1 Ternstroemia kwangtungensis -- References -- Chapter 4: Medicinal Angiosperms of Actinidiaceae, Saurauiaceae, Myrtaceae, and Melastomataceae -- 4.1 Family: Actinidiaceae -- 4.1.1 Actinidia callosa var. henryi -- 4.2 Family: Actinidiaceae -- 4.2.1 Actinidia chinensis [1] -- 4.3 Family: Actinidiaceae -- 4.3.1 Actinidia eriantha [2] -- 4.4 Family: Actinidiaceae -- 4.4.1 Actinidia latifolia -- 4.5 Family: Saurauiaceae -- 4.5.1 Saurauia tristyla -- 4.6 Family: Myrtaceae -- 4.6.1 Baeckea frutescens -- 4.7 Family: Myrtaceae -- 4.7.1 Cleistocalyx operculatus -- 4.8 Family: Myrtaceae -- 4.8.1 Eucalyptus citriodora -- 4.9 Family: Myrtaceae -- 4.9.1 Eucalyptus robusta -- 4.10 Family: Myrtaceae -- 4.10.1 Eugenia caryophyllata [3] -- 4.11 Family: Myrtaceae -- 4.11.1 Melaleuca leucadendron -- 4.12 Family: Myrtaceae -- 4.12.1 Psidium guajava -- 4.13 Family: Myrtaceae -- 4.13.1 Rhodomyrtus tomentosa -- 4.14 Family: Myrtaceae. 4.14.1 Syzygium buxifolium -- 4.15 Family: Myrtaceae -- 4.15.1 Syzygium grijsii -- 4.16 Family: Myrtaceae -- 4.16.1 Syzygium jambos -- 4.17 Family: Melastomataceae -- 4.17.1 Blastus cochinchinensis -- 4.18 Family: Melastomataceae -- 4.18.1 Fordiophyton faberi -- 4.19 Family: Melastomataceae -- 4.19.1 Fordiophyton fordii -- 4.20 Family: Melastomataceae -- 4.20.1 Melastoma affine -- 4.21 Family: Melastomataceae -- 4.21.1 Melastoma candidum -- 4.22 Family: Melastomataceae -- 4.22.1 Melastoma dodecandrum -- 4.23 Family: Melastomataceae -- 4.23.1 Melastoma intermedium -- 4.24 Family: Melastomataceae -- 4.24.1 Melastoma normale -- 4.25 Family: Melastomataceae -- 4.25.1 Melastoma sanguineum -- 4.26 Family: Melastomataceae -- 4.26.1 Osbeckia chinensis -- 4.27 Family: Melastomataceae -- 4.27.1 Osbeckia opipara -- 4.28 Family: Melastomataceae -- 4.28.1 Sonerila cantonensis -- References -- Chapter 5: Medicinal Angiosperms of Combretaceae, Rhizophoraceae, and Hypericaceae -- 5.1 Family: Combretaceae -- 5.1.1 Combretum alfredii -- 5.2 Family: Combretaceae -- 5.2.1 Quisqualis indica [1] -- 5.3 Family: Combretaceae -- 5.3.1 Terminalia catappa [2] -- 5.4 Family: Combretaceae -- 5.4.1 Terminalia chebula -- 5.5 Family: Rhizophoraceae -- 5.5.1 Carallia longipes -- 5.6 Family: Rhizophoraceae -- 5.6.1 Ceriops tagal -- 5.7 Family: Rhizophoraceae -- 5.7.1 Kandelia candel -- 5.8 Family: Rhizophoraceae -- 5.8.1 Rhizophora mucronata -- 5.9 Family: Hypericaceae -- 5.9.1 Cratoxylum cochinchinense -- 5.10 Family: Hypericaceae -- 5.10.1 Hypericum ascyron -- 5.11 Family: Hypericaceae -- 5.11.1 Hypericum attenuatum -- 5.12 Family: Hypericaceae -- 5.12.1 Hypericum chinense -- 5.13 Family: Hypericaceae -- 5.13.1 Hypericum erectum -- 5.14 Family: Hypericaceae -- 5.14.1 Hypericum japonicum -- 5.15 Family: Hypericaceae -- 5.15.1 Hypericum patulum -- 5.16 Family: Hypericaceae. 5.16.1 Hypericum perforatum [3] -- 5.17 Family: Hypericaceae -- 5.17.1 Hypericum sampsonii -- References -- Chapter 6: Medicinal Angiosperms of Guttiferae, Tiliaceae, Sterculiaceae, and Bombacaceae -- 6.1 Family: Guttiferae -- 6.1.1 Garcinia multiflora -- 6.2 Family: Guttiferae -- 6.2.1 Garcinia oblongifolia -- 6.3 Family: Tiliaceae -- 6.3.1 Corchoropsis tomentosa -- 6.4 Family: Tiliaceae -- 6.4.1 Corchorus aestuans -- 6.5 Family: Tiliaceae -- 6.5.1 Corchorus capsularis -- 6.6 Family: Tiliaceae -- 6.6.1 Grewia biloba -- 6.7 Family: Tiliaceae -- 6.7.1 Grewia eriocarpa -- 6.8 Family: Tiliaceae -- 6.8.1 Microcos paniculata [1] -- 6.9 Family: Tiliaceae -- 6.9.1 Triumfetta rhomboidea [2] -- 6.10 Family: Sterculiaceae -- 6.10.1 Ambroma augusta -- 6.11 Family: Sterculiaceae -- 6.11.1 Byttneria aspera -- 6.12 Family: Sterculiaceae -- 6.12.1 Firmiana simplex -- 6.13 Family: Sterculiaceae -- 6.13.1 Helicteres angustifolia -- 6.14 Family: Sterculiaceae -- 6.14.1 Helicteres isora -- 6.15 Family: Sterculiaceae -- 6.15.1 Pterospermum heterophyllum [3] -- 6.16 Family: Sterculiaceae -- 6.16.1 Pterospermum lanceifolium -- 6.17 Family: Sterculiaceae -- 6.17.1 Sterculia nobilis -- 6.18 Family: Sterculiaceae -- 6.18.1 Waltheria indica -- 6.19 Family: Bombacaceae -- 6.19.1 Bombax ceiba -- References -- Chapter 7: Medicinal Angiosperms of Malvaceae and Malpighiaceae -- 7.1 Family: Malvaceae -- 7.1.1 Abelmoschus esculentus -- 7.2 Family: Malvaceae -- 7.2.1 Abelmoschus moschatus -- 7.3 Family: Malvaceae -- 7.3.1 Abelmoschus sagittifolius -- 7.4 Family: Malvaceae -- 7.4.1 Abutilon indicum [1] -- 7.5 Family: Malvaceae -- 7.5.1 Abutilon theophrasti [2] -- 7.6 Family: Malvaceae -- 7.6.1 Althaea rosea -- 7.7 Family: Malvaceae -- 7.7.1 Gossypium herbaceum -- 7.8 Family: Malvaceae -- 7.8.1 Hibiscus mutabilis [3] -- 7.9 Family: Malvaceae -- 7.9.1 Hibiscus rosa-sinensis. 7.10 Family: Malvaceae. |
Record Nr. | UNINA-9910512186403321 |
Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Common Chinese Materia Medica : Volume 9 / / edited by Huagu Ye, Chuyuan Li, Wencai Ye, Feiyan Zeng |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 |
Descrizione fisica | 1 online resource (758 pages) |
Disciplina | 610.951 |
Soggetto topico |
Pharmacy
Medicine Botany Clinical Medicine Plant Science Medicina xinesa |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-5920-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Medicinal angiosperms of Hydrocharitaceae -- Alismataceae -- Potamogetonaceae -- Commelinaceae -- Eriocaulaceae -- Musaceae. |
Record Nr. | UNINA-9910520062703321 |
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Molecular Pharmacognosy / / edited by Lu-qi Huang |
Edizione | [2nd ed. 2019.] |
Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (xix, 303 pages) : illustrations |
Disciplina | 615.321 |
Soggetto topico |
Pharmacology
Medicinal chemistry Plant biochemistry Molecular biology Plant science Botany Pharmacology/Toxicology Medicinal Chemistry Plant Biochemistry Molecular Medicine Plant Sciences Farmacognòsia Medicina xinesa Biología molecular |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-329-034-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Emerging Molecular Pharmacognosy -- Molecular Identification of Traditional Medicinal Materials -- Molecular phylogeography of Medicinal plants -- The Mechanism of Formation of Dao-di herbs -- Seeking for New members of Origin Materials for CMM -- Salvation of Rare and Endangered Medicinal Plants -- Functional Genome of medicinal plants -- Gene Modification of Pharmic Plant Germplasm Resources -- Regulation of the Active Constituents’ Production of medicinal Plants -- Synthetic biology of active compounds. |
Record Nr. | UNINA-9910373911903321 |
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Novel drug delivery systems for Chinese medicines / / Nianping Feng, Zhijun Yang, editors |
Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (342 pages) |
Disciplina | 615.6 |
Soggetto topico |
Drug delivery systems
Medicine, Chinese Pharmacology Gestió farmacèutica Medicina xinesa |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-16-3444-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Editorial Board -- Preface -- Marketing Text -- Contents -- About the Editors -- Chapter 1: A Historical Overview and Concepts of Chinese Medicine Preparations and Novel Delivery Systems -- 1.1 Introduction -- 1.2 Characteristics of Chinese Medicines -- 1.2.1 Medicinal Materials´ Growing Areas and Geo-Authentic Medicinal Materials (Daodi Yaocai) -- 1.2.2 Harvesting of Chinese Medicinal Materials -- 1.2.3 Processing of Medicinal Materials -- 1.2.4 Compatibility of Chinese Medicines -- 1.3 Active Substances of Chinese Medicine Preparations -- 1.3.1 Diversity of the Active Substances of Chinese Medicine Preparations -- 1.3.1.1 Diversity of Source -- 1.3.1.2 Diversity of Ingredients and Effects -- 1.3.1.3 Diversity of Factors Affecting the Quality -- 1.3.2 Types of Active Substances of Chinese Medicine Preparations -- 1.3.2.1 Decoction Pieces -- 1.3.2.2 Volatile Oil and Fatty Oil -- 1.3.2.3 Extracts -- 1.3.2.4 Active Ingredients -- 1.3.3 Preparation of Active Substances of Chinese Medicine Preparations -- 1.3.3.1 Pretreatment of Chinese Medicinal Materials -- 1.3.3.2 Extraction -- 1.3.3.3 Separation and Purification -- 1.3.3.4 Concentration and Drying -- 1.4 NDDS of Chinese Medicines -- 1.4.1 Design of NDDS for Chinese Medicines -- 1.4.2 NDDS Technologies Used in Chinese Medicines -- 1.4.2.1 Oral Sustained-Release Systems -- 1.4.2.2 Sustained-Release Systems for Intravenous Administration -- 1.4.2.3 In Situ Forming Drug Delivery Systems -- 1.4.2.4 Transdermal Drug Delivery Systems -- 1.4.2.5 Mucosal Drug Delivery Systems -- 1.4.2.6 Targeted Drug Delivery Systems -- 1.4.2.7 Smart Drug Delivery Systems -- 1.5 Novel Pharmaceutical Technologies for Chinese Medicines -- 1.5.1 Inclusion Compounds -- 1.5.2 Solid Dispersion -- 1.5.3 Microcapsules and Microspheres -- 1.5.4 Pharmaceutical Nanotechnologies -- 1.6 Multi-Component Drug Delivery System.
1.7 Conclusions -- References -- Chapter 2: Multi-Component Drug Delivery Systems for Chinese Medicines Based on the TCM Theory -- 2.1 Introduction -- 2.2 Properties of Components -- 2.2.1 Medicine Properties of Components -- 2.2.1.1 Four Natures of Components -- 2.2.1.2 Five Tastes of Components -- 2.2.1.3 Channel Tropism of Components -- 2.2.1.4 Ascending and Descending of Components -- 2.2.1.5 Toxic of Components -- 2.2.2 Physical Properties of Components -- 2.2.2.1 Physicochemical Properties and Structure Characteristics of Components -- 2.2.2.2 ADME Properties and Pharmacokinetic Characteristics of Components -- 2.2.2.3 Pharmaceutical Properties of Components -- 2.3 Unit Preparation Techniques for Components -- 2.3.1 Solubilization of Difficult Soluble Components -- 2.3.2 Strategies to Improve or to Promote the Permeability of Components -- 2.3.2.1 Increasing Mucosal Permeability of Components -- 2.3.2.2 Promoting Cellular Permeability of Components -- 2.3.2.3 Other Ways to Improve the Permeability of Components -- 2.3.3 New Ideas for the Design of Component Unit Preparation -- 2.3.3.1 Utilization of Physicochemical Synergy Between Components -- 2.3.3.2 Using Suitable Carrier to Transport Components -- 2.4 Design of MCDDS -- 2.4.1 Design of MCDDS Based on MPCs -- 2.4.1.1 Design Based on CFN -- 2.4.1.2 Design Based on CFT -- 2.4.1.3 Design Based on CCT -- 2.4.1.4 Design Based on CAD -- 2.4.1.5 Design Based on CT -- 2.4.2 Design Based on the Characteristics of a Disease -- 2.4.2.1 According to the Priority of Syndromes of a Disease -- 2.4.2.2 According to the Rhythm of Pathophysiology -- 2.4.3 Difficulties in the Design of MCDDS -- 2.5 Establishing a Scientific Evaluation System for MCDDS -- 2.5.1 The Evaluations of MCDDS in Vitro -- 2.5.2 The Evaluations for MCDDS in Vivo -- 2.5.3 The Evaluations for Toxicity and Side Effects of MCDDS. 2.6 Conclusions and Prospects -- References -- Chapter 3: Sustained-Release Drug Delivery Systems of Chinese Medicines -- 3.1 Introduction -- 3.2 Sustained Delivery of Various Bioactive Ingredients from Chinese Medicine -- 3.2.1 Sustained Delivery of Bioactive Alkaloids -- 3.2.2 Sustained Delivery of Bioactive Glycosides -- 3.2.3 Sustained Delivery of Bioactive Phenolic Acids -- 3.2.4 Sustained Delivery of Bioactive Polysaccharides -- 3.2.5 Others -- 3.3 Sustained-Release Preparations of TCM Compound Recipes -- 3.3.1 Membrane-Controlled Type -- 3.3.2 Matrix Type -- 3.3.3 Osmotic Type -- 3.3.4 Intragastric Floating Type -- 3.4 The Quality Evaluation of Sustained-Release DDSs of Chinese Medicines -- 3.5 Conclusion -- References -- Chapter 4: Transdermal Delivery of Chinese Medicine -- 4.1 Introduction -- 4.2 Chinese Medicine Essential Oils as Penetration Enhancers -- 4.2.1 Mechanism of Penetration Enhancement -- 4.2.2 Role of ``Four Natures´´ -- 4.2.3 Percutaneous Absorption of EO Components -- 4.3 Techniques in Increasing Physical Penetration -- 4.3.1 Microneedles -- 4.3.2 Iontophoresis -- 4.3.3 Sonophoresis -- 4.3.4 Cupping Therapy -- 4.4 Nanocarriers for Transdermal Delivery of Chinese Medicine -- 4.4.1 Liposomes -- 4.4.2 Nanoparticles -- 4.4.3 Nanoemulsions -- 4.5 Transdermal Evaluation Technique -- 4.6 Conclusion -- References -- Chapter 5: The Contribution of Traditional Chinese Medicine Compound in Nasal Drug Delivery System -- 5.1 Nasal Therapy Under Traditional Chinese Medicine Theory -- 5.2 The Understanding of Nasal Therapy in Western Natural Medicine -- 5.3 Development in Anatomy -- 5.4 Development of Modern Preparations -- 5.4.1 Nasal Drops -- 5.4.2 Aerosols and Sprays -- 5.4.3 Gelling Agent and in Situ Gel -- 5.4.4 Microemulsion -- 5.4.5 Liposome -- 5.4.6 Nanoparticles -- 5.4.7 Summary. 5.5 The Combination of Traditional Chinese Medicine and Modern Preparations -- 5.5.1 Inclusive Compound Preparation Technology -- 5.5.2 Solid Dispersion Technology -- 5.5.3 Microsphere Preparation Technology -- 5.5.4 Nanotechnology -- 5.6 Problems and Prospects -- 5.6.1 Problems -- 5.6.2 Prospects -- References -- Chapter 6: Brain-Targeting Drug Delivery Systems for Chinese Medicines -- 6.1 Introduction -- 6.2 Physiological Barrier of the Brain for Drug Delivery -- 6.3 Brain-Targeting Drug Delivery Strategies for Chinese Medicines -- 6.3.1 Intranasal Drug Delivery Systems -- 6.3.2 Brain Penetration Enhancers -- 6.3.2.1 Aromatic Penetration Enhancers from Chinese Medicines -- 6.3.2.2 Non-aromatic Penetration Enhancers from Chinese Medicines -- 6.3.2.3 Vasoactive Substances -- 6.3.3 Prodrug Delivery Systems -- 6.3.3.1 Ligand Modification -- 6.3.3.2 Chemical Modification -- 6.3.4 Nanoparticle Drug Delivery Systems -- 6.3.5 Other Drug Delivery Systems -- 6.4 Conclusion -- References -- Chapter 7: Chinese Herbal Medicine and Targeted Delivery Strategy for the Treatment of Kidney Disease -- 7.1 Introduction -- 7.2 Structure and Physiological Function of the Kidney -- 7.2.1 Structure -- 7.2.1.1 Renal Corpuscle -- 7.2.1.2 Renal Tubules -- 7.3 Chinese Herbal Medicine in the Treatment of CKD -- 7.3.1 Huangqi (Astragali Radix) -- 7.3.2 Dahuang (Rhei Radix et Rhizoma) -- 7.3.3 Danshen (Salviae Miltiorrhizae Radix et Rhizoma) -- 7.3.4 Leigongteng (Radix et Rhizoma Tripterygii) -- 7.3.5 Danggui (Angelica Sinensis Radix) -- 7.3.6 Others -- 7.4 Kidney-Targeted Delivery Strategy -- 7.4.1 Targeting Glomerulus -- 7.4.1.1 Targeting Mesangial Cell -- 7.4.1.2 Targeting Podocytes -- 7.4.2 Targeting Proximal Tubules -- 7.4.2.1 Targeting Megalin and Cubilin Receptors -- 7.4.2.2 Targeting Folate Receptor -- 7.5 Conclusions -- References. Chapter 8: Liposomes and Their Application in the Delivery of Herbal Active Ingredients -- 8.1 History of Liposomes -- 8.2 The Composition of Liposomes -- 8.2.1 Liposomal Vesicles (Lipid Vesicles) -- 8.2.2 The Composition of Liposomes -- 8.3 Preparation -- 8.3.1 Relationship Between the Type and the Preparation Method -- 8.3.2 Method of Preparation -- 8.3.3 Surface Modification -- 8.3.4 Loading or Entrapment of Drugs -- 8.4 The Qualities of Liposomes -- 8.4.1 Liposomes Membrane -- 8.4.2 Entrapped Volume and Capture Efficiency -- 8.4.3 The Morphology and Size of Liposomes -- 8.4.3.1 Selective Permeability and Fluidity Permeability -- 8.4.4 Charges, pH, and Calcium -- 8.4.5 Stability and Storage -- 8.5 The Application of Liposomes in Chinese Medicine -- 8.6 Conclusion -- References -- Chapter 9: Microparticulate Drug Delivery Systems for Chinese Medicines -- 9.1 Introduction -- 9.2 Types and Components of Microparticles of Chinese Medicine -- 9.2.1 Core Materials -- 9.2.2 Coating Materials -- 9.3 Fabrication of Microparticulate DDS of Chinese Medicine -- 9.3.1 Solvent Evaporation -- 9.3.2 Coacervation -- 9.3.3 Spray Drying Method -- 9.3.4 Other Methods -- 9.3.4.1 Supercritical Fluid Technique -- 9.3.4.2 Hydrogel-Template Technique -- 9.4 Characterization of Microparticulate DDS of Chinese Medicine -- 9.4.1 Particle Size and Size Distribution -- 9.4.2 Morphology and Structure -- 9.4.3 Drug Loading Capacity and Release Pattern -- 9.4.4 Drug-Excipient Interaction -- 9.5 Application of Microparticulate DDS of Chinese Medicine -- 9.5.1 Solidification and Powderization -- 9.5.2 Prolonged-Release for Improved Bioavailability -- 9.5.3 Targeted or Site-Specific Drug Delivery -- 9.5.4 Biomedical Engineering -- 9.5.5 Other Applications -- 9.6 Conclusion and Prospects -- References -- Chapter 10: Hydrogels for Delivery of Chinese Medicines -- 10.1 Introduction. 10.2 Effects of Hydrogels in Improving In Vivo Efficacies of Drugs. |
Record Nr. | UNINA-9910512306903321 |
Gateway East, Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|